Skip to content
Open access · US-GOV via ClinicalTrials.gov Clinical trial

Open Label Study of Isotretinoin in Mild to Moderate Alzheimer's Disease

Authors not listed

University Hospitals Cleveland Medical Center · 2012

Abstract

This is an open label study of isotretinoin, a medication which is FDA approved for treatment of other conditions to determine initial safety in Alzheimer's disease.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
ClinicalTrials.gov
Canonical
link ↗
Fetched
2026-11-01 MST

Cite this

APA
Anonymous. (2012). Open Label Study of Isotretinoin in Mild to Moderate Alzheimer's Disease. <em>University Hospitals Cleveland Medical Center</em>. https://clinicaltrials.gov/study/NCT01560585
Vancouver
Anonymous. Open Label Study of Isotretinoin in Mild to Moderate Alzheimer's Disease. University Hospitals Cleveland Medical Center. 2012.
BibTeX
@misc{anon2012OpenLa, title = {Open Label Study of Isotretinoin in Mild to Moderate Alzheimer's Disease}, author = {Anonymous}, journal = {University Hospitals Cleveland Medical Center}, year = {2012}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings